Hysterectomy Introduction
It is important to remember that you are not alone. In the U.S. there are over 600,000 hysterectomies performed each year, about 1,643 a day.
It is important to remember that you are not alone. In the U.S. there are over 600,000 hysterectomies performed each year, about 1,643 a day. In fact, by the age of 60, 1 in 3 women will have had a hysterectomy. This site is intended to provide you with facts so you can make an informed decision with your health care provider about your choices.
Today's hysterectomy choices include innovative, minimally-invasive procedures that can be modified by your doctor to address the treatment and relief of your symptoms. These new advanced surgical techniques reduce the pain and minimize the scarring from surgery, typically require only one day in the hospital, and get you back to your normal routine in less than a week on average. Click on Hysterectomy Options for more information.
Hysterectomy Quick Facts
- 600,000 hysterectomies are performed each year in USA
- 65% of hysterectomies are performed each year in the US
- Minimally invasive procedures are available and you may be a good candidate
References:
Sources
1. Hoffman C, Kennedy J, Borschel L, Burchette R, Kidd A. Laparoscopic Hysterectomy: The Kaiser Permanente San Diego experience. Journal of Minimally Invasive Gynecology 2005;12:16-24.
Important Note to Reader: The information in these Web pages is for your general knowledge and background only. Note that these Web pages contain information from various sources considered to be dependable. However, we make no representations, warranties or other expressed or implied warranties or guarantees regarding the accuracy, reliability or completeness of the information. Under no circumstance shall Gyrus ACMI, Inc., Olympus America Inc. and/or its or their respective affiliates, employees, consultants, agents or representatives (collectively "Gyrus") be liable for any costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be in incurred in connection with the information provided or any use thereof.
© 2010 Gyrus ACMI, Inc. All rights reserved. | Privacy Policy | Legal Notice
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More
